Replies to post #18879 on Lifeline Biotechnologies Inc (LLBO)

[philipt631]

I see sales starting outside the U.S. in a few countries by the third quarter. Countries like Singapore and India being the first two.

They need to begin sales in a few countries outside the U.S. where they not as tied up in "red tape"

[MEAD II]

THIS IS AN ANNOTATED RE-POST FROM 11/06/2015 --

... IMO, once the train begins to move in that direction, LLBO will be bought out by an established player such as CSCO at about $3.00 per share in CSCO stock. Corporate stock is a viable currency and CSCO, after 9 splits over the last 10-15 years is valued at 00.06 per share. Taking that into consideration, with the iTBra as a game changing industry advance, this opinion is not as far afield as it might sound. IMO this is breakthrough technology and may also attract interest from players like GE or Siemens who currently build and support the mammogram machines around the world; and hold another vested interest. As I see it, the iTBra is part science, part business and part doing work for the grater good. We need the NEXT parent company with the fiscal staying power to go toe to toe with those who currently control that status quo. With that said, while there are bright days on the horizon, the road going forward following the trials and entry to the market place will not be mastered without experiencing potential road blocks. GLTA!